| Name | Title | Contact Details |
|---|
At Gate City Bank, we invest in the best people...driven people, compassionate people, creative people…people like you! We invest in the best team members because its whats best for our customers. We are investing in our team members with competitive compensation and comprehensive benefits packages, along with promoting a fun, family-friendly work environment. Gate City Bank is a mutual community bank and we have been providing complete banking services to our customers since 1923. It is Gate City Banks privilege to be a hometown bank that provides excellent service that is convenient, friendly, and personalized. We are proud to be the #1 mortgage lender in North Dakota with locally approved and financed home loans. Gate City Bank is also unique in offering our checking customers FREE ATMs anywhere with unlimited ATM fee refunds, which has saved our customers more than $33 million since we began refunding ATM fees in 2006. Thats what its all about here at Gate City Bank - making your financial life easier, more convenient, and more rewarding so you can enjoy a better way of life. Gate City Bank is honored to support our communities through charitable contributions, in-kind donations such as reduced interest-rate loans for non-profit organizations, and paid volunteer time for our team members. We go beyond our commitment to offering the best checking, savings, and loan programs – were touching lives in the communities we serve. With 43 locations across North Dakota and central Minnesota, Gate City Bank shares a commitment to our customers, communities, and team members. Member FDIC - Equal Housing Lender - EOE, including Disability/Vets
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
At Flow, AI isnt just a feature—its the core of everything we do. We are transforming the wholesale insurance industry by building a futuristic insurance brokerage where AI powers every aspect of the experience. With advanced AI features already live in production and actively used by our brokers, we are pioneering Wholesale 3.0, equipping brokers with cutting-edge tools to provide unparalleled service. We are creating an ecosystem of AI agents designed to streamline processes and enhance decision-making in the insurance landscape. The industry relies heavily on text—emails, files, and documents—making Generative AI a perfect fit for solving its challenges. Flow leverages AI to deliver meaningful insights, deep analysis, and white-glove support for every transaction, no matter the deal size. By combining human expertise with Platformless AI, we are bringing back the art of wholesale insurance while eliminating the need for outdated portals. In the past seven months, weve grown 250% month-over-month(!) and are forecasting even more massive growth. Were a Series A startup with over $20M raised from top investors like Lightspeed, MunichRe Ventures, and industry angels.
Public Risk Innovation, Solutions, and Management, PRISM, is a member-directed risk sharing pool of counties and public entities committed to providing risk coverage programs and risk management services.